PT2912165T - Populações de células renais e utilizações das mesmas - Google Patents

Populações de células renais e utilizações das mesmas

Info

Publication number
PT2912165T
PT2912165T PT13786132T PT13786132T PT2912165T PT 2912165 T PT2912165 T PT 2912165T PT 13786132 T PT13786132 T PT 13786132T PT 13786132 T PT13786132 T PT 13786132T PT 2912165 T PT2912165 T PT 2912165T
Authority
PT
Portugal
Prior art keywords
cell populations
renal cell
renal
populations
cell
Prior art date
Application number
PT13786132T
Other languages
English (en)
Inventor
Basu Joydeep
Guthrie Kelly
JUSTEWICZ Dominic
Burnette Teresa
Bruce Andrew
W Kelley Russell
W Ludlow John
Original Assignee
Inregen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inregen filed Critical Inregen
Publication of PT2912165T publication Critical patent/PT2912165T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT13786132T 2012-10-24 2013-10-24 Populações de células renais e utilizações das mesmas PT2912165T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261718150P 2012-10-24 2012-10-24
US201361876616P 2013-09-11 2013-09-11

Publications (1)

Publication Number Publication Date
PT2912165T true PT2912165T (pt) 2019-09-26

Family

ID=49517782

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13786132T PT2912165T (pt) 2012-10-24 2013-10-24 Populações de células renais e utilizações das mesmas

Country Status (18)

Country Link
US (4) US20150246073A1 (pt)
EP (3) EP3901251A1 (pt)
JP (2) JP6509119B2 (pt)
KR (5) KR102460536B1 (pt)
CN (3) CN104937095B (pt)
AU (3) AU2013334276B2 (pt)
BR (2) BR122020018576B1 (pt)
CA (2) CA2889270A1 (pt)
DK (2) DK2912165T3 (pt)
ES (2) ES2744979T3 (pt)
HK (1) HK1215448A1 (pt)
HU (2) HUE046176T2 (pt)
NZ (2) NZ741724A (pt)
PL (2) PL3567099T3 (pt)
PT (1) PT2912165T (pt)
RU (1) RU2702721C2 (pt)
SI (1) SI2912165T1 (pt)
WO (1) WO2014066699A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122020018576B1 (pt) 2012-10-24 2022-07-05 Inregen Método de preparação de uma composição terapêutica adequada para gerar uma resposta regenerativa em um rim de um indivíduo, composição terapêutica e uso da mesma
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
BR122019015270B1 (pt) * 2016-07-29 2022-03-03 Timothy A. Bertram Uso de uma composição compreendendo uma população de células renais selecionadas para o tratamento de nefropatia diabética
AU2018243725A1 (en) * 2017-03-31 2019-10-17 Prokidney Injectable cell and scaffold compositions
JP2020525003A (ja) * 2017-06-21 2020-08-27 バートナム，ティモシー，エー． 腎臓病治療のための免疫特権を有する生物活性腎細胞
JP7061766B2 (ja) * 2017-09-20 2022-05-02 学校法人同志社 Ｄｊ－１タンパク質産生促進用組成物
CN109266616A (zh) * 2018-08-21 2019-01-25 山西省人民医院 一种稳定表达aqp2蛋白的人源化小鼠足细胞模型及其构建方法和应用
CA3108729A1 (en) * 2018-08-31 2020-03-05 Timothy Bertram Compositions comprising cell-derived vesicles and uses thereof
KR20220022125A (ko) * 2019-05-02 2022-02-24 티모시 에이. 버트람 신장 및/또는 요로 기형을 갖는 대상체에서의 신장 질환의 치료
IL295156A (en) * 2020-01-28 2022-09-01 Kidneycure Ltd Process for production of kidney cells and treatment
CN116240161B (zh) * 2023-02-27 2024-05-10 四川大学华西医院 具有肾脏损伤修复作用的细胞外囊泡制备方法及应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
CA2046830C (en) 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
ES2159726T3 (es) 1995-03-10 2001-10-16 Roche Diagnostics Gmbh Formas de administracion farmaceuticas que contienen polipeptidos, en forma de microparticulas, y procedimiento para su fabricacion.
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
DE69817863T2 (de) 1997-10-31 2004-07-15 Children's Medical Center Corp., Boston Blasenrekonstruktion
ATE281155T1 (de) 1998-04-20 2004-11-15 Genzyme Corp Medikamentöse verabreichung von proteinen aus polymergemischen
DE19933582A1 (de) 1999-07-17 2001-01-18 Gerhard Rosenberger Vorrichtung zum Aufnehmen von Werkstücken und/oder Werkzeugen
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
US7197470B1 (en) 2000-10-11 2007-03-27 Buzzmetrics, Ltd. System and method for collection analysis of electronic discussion methods
JP2004531713A (ja) * 2001-04-03 2004-10-14 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング 腎細胞癌の腫瘍マーカー
JP2005523888A (ja) * 2002-01-03 2005-08-11 ザ スクリプス リサーチ インスティテュート 癌関連エピトープ
WO2003080038A1 (fr) 2002-03-22 2003-10-02 Kissei Pharmaceutical Co., Ltd. Agent prophylactique ou therapeutique contre des maladies renales
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US20040139072A1 (en) 2003-01-13 2004-07-15 Broder Andrei Z. System and method for locating similar records in a database
US20050241012A1 (en) * 2003-10-17 2005-10-27 Nigam Sanjay K Multigene profiling in the kidney to tailor drug therapy
US20050108384A1 (en) 2003-10-23 2005-05-19 Lambert John R. Analysis of message sequences
US7788087B2 (en) 2005-03-01 2010-08-31 Microsoft Corporation System for processing sentiment-bearing text
US20080161231A1 (en) * 2005-03-18 2008-07-03 Kintan Pty. Ltd. Methods and compositions for promoting organ development
WO2006117889A1 (ja) * 2005-04-28 2006-11-09 Stemcell Institute Inc. 移植用臓器の調製方法
JP5416415B2 (ja) 2006-02-10 2014-02-12 テンジオン， インコーポレイテッド 臓器の再建および増強のための骨格
JP2009528639A (ja) 2006-02-28 2009-08-06 バズロジック， インコーポレイテッド ソーシャルメディアにおける会話を分析するためのソーシャル分析システムおよび方法
WO2008045498A1 (en) 2006-10-12 2008-04-17 Ethicon, Inc. Kidney-derived cells and methods of use in tissue repair and regeneration
US8048636B2 (en) * 2007-03-05 2011-11-01 Northshore University Healthsystem Methods of screening for modulators of h2-calponin activity
AU2008262333B2 (en) 2007-06-08 2014-07-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
RU2373942C2 (ru) * 2007-12-26 2009-11-27 Федеральное государственное учреждение "Научный Центр акушерства, гинекологии и перинатологии Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения хронической и острой почечной недостаточности с помощью фетальных стволовых и прогениторных клеток
EP3708682B1 (en) 2008-02-01 2022-11-23 The General Hospital Corporation Use of microvesicles in diagnosis and prognosis of medical diseases and conditions
CA2742599A1 (en) 2008-11-04 2010-05-14 Tengion, Inc. Cell-scaffold constructs
EP2186883A1 (en) * 2008-11-04 2010-05-19 Fresenius Medical Care An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
KR102357077B1 (ko) * 2008-11-12 2022-01-27 인리젠 분리된 신장 세포 및 이의 용도
CA2770266A1 (en) * 2009-08-07 2011-02-10 Rules-Based Medicine, Inc. Methods and devices for detecting kidney damage
CA2780320A1 (en) * 2009-11-12 2011-05-19 Tengion, Inc. Rational design of regenerative medicine products
WO2011096894A2 (en) 2010-02-04 2011-08-11 Agency For Science Technology And Research Use of novel markers of pluripotent stem cells
CN103025361B (zh) 2010-05-03 2016-05-25 再生医学Tx有限责任公司 平滑肌细胞结构
CN106214700B (zh) * 2010-05-12 2021-09-07 因瑞金公司 生物活性肾细胞
WO2011156642A1 (en) 2010-06-11 2011-12-15 Tengion, Inc. Erythropoietin-expressing adipose cell populations
CA3065694A1 (en) * 2010-11-10 2012-05-18 Inregen Methods of forming injectable formulations for providing regenerative effects to an organ such as a kidney
WO2013049856A2 (en) * 2011-09-30 2013-04-04 Hare Joshue M Renal stem cells isolated from kidney
US20140308695A1 (en) 2011-11-04 2014-10-16 Tengion, Inc. Drug screening and potency assays
BR122020018576B1 (pt) 2012-10-24 2022-07-05 Inregen Método de preparação de uma composição terapêutica adequada para gerar uma resposta regenerativa em um rim de um indivíduo, composição terapêutica e uso da mesma
US9213997B2 (en) 2012-10-24 2015-12-15 Moodwire, Inc. Method and system for social media burst classifications
KR20240090622A (ko) * 2013-05-08 2024-06-21 인리젠 단리된 신장 세포를 포함하는 오가노이드 및 이의 용도
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
JP2020525003A (ja) * 2017-06-21 2020-08-27 バートナム，ティモシー，エー． 腎臓病治療のための免疫特権を有する生物活性腎細胞
EP4243837A1 (en) * 2020-11-13 2023-09-20 Timothy A. Bertram Enriched bioactive renal cell populations, characteristics and uses thereof

Also Published As

Publication number Publication date
KR102460536B1 (ko) 2022-10-31
BR112015009042A8 (pt) 2017-10-10
AU2019204178B2 (en) 2021-11-18
KR20150085818A (ko) 2015-07-24
JP2019141067A (ja) 2019-08-29
KR20210018965A (ko) 2021-02-18
ES2744979T8 (es) 2020-04-28
ES2744979T3 (es) 2020-02-27
EP3567099B1 (en) 2021-04-21
CN104937095A (zh) 2015-09-23
EP2912165B1 (en) 2019-06-19
KR20240096798A (ko) 2024-06-26
JP6696023B2 (ja) 2020-05-20
NZ707873A (en) 2019-01-25
US20150246073A1 (en) 2015-09-03
RU2015119514A (ru) 2016-12-20
DK2912165T3 (da) 2019-09-16
ES2876177T3 (es) 2021-11-12
RU2019118791A (ru) 2019-07-11
KR102160725B1 (ko) 2020-09-29
HK1215448A1 (zh) 2016-08-26
HUE046176T2 (hu) 2020-02-28
EP2912165A1 (en) 2015-09-02
US20170281684A1 (en) 2017-10-05
CA2889270A1 (en) 2014-05-01
AU2019204178A1 (en) 2019-07-04
US20220347221A1 (en) 2022-11-03
CA3240629A1 (en) 2014-05-01
WO2014066699A1 (en) 2014-05-01
KR20200113287A (ko) 2020-10-06
HUE054882T2 (hu) 2021-10-28
CN110184232A (zh) 2019-08-30
CN117660296A (zh) 2024-03-08
JP6509119B2 (ja) 2019-05-08
CN104937095B (zh) 2019-06-07
US11369639B2 (en) 2022-06-28
AU2022201010A1 (en) 2022-03-03
KR20220150419A (ko) 2022-11-10
AU2013334276A1 (en) 2015-05-14
BR112015009042B1 (pt) 2021-10-19
EP3901251A1 (en) 2021-10-27
RU2702721C2 (ru) 2019-10-09
AU2013334276B2 (en) 2019-07-04
DK3567099T3 (da) 2021-06-07
KR102215476B1 (ko) 2021-02-17
CN110184232B (zh) 2023-10-20
JP2016504017A (ja) 2016-02-12
EP3567099A1 (en) 2019-11-13
BR122020018576B1 (pt) 2022-07-05
PL3567099T3 (pl) 2021-11-29
SI2912165T1 (sl) 2019-11-29
PL2912165T3 (pl) 2020-01-31
KR102674303B1 (ko) 2024-06-12
US20200101112A1 (en) 2020-04-02
US10363274B2 (en) 2019-07-30
BR112015009042A2 (pt) 2017-07-04
NZ741724A (en) 2020-02-28

Similar Documents

Publication Publication Date Title
HK1251033A1 (zh) 全細胞分析和方法
HK1213016A1 (zh) 細胞調節化合物及其用途
HK1211623A1 (en) Cell lines
HK1215448A1 (zh) 腎細胞群及其用途
EP2862225A4 (en) DESIGN OF A REDOX FLUX BATTERY WITH SEVERAL MEMBRANES AND SEVERAL ELECTRODES
EP2919313A4 (en) SOLID ELECTROLYTE
EP2858140A4 (en) BATTERY BOX
EP2863471A4 (en) SECONDARY BATTERY SYSTEM AND ERROR DETECTION SYSTEM FOR SECONDARY BATTERY
AU347859S (en) Battery
AU346864S (en) Battery
EP2824749A4 (en) BATTERY WITH A COATED STRUCTURE
HK1207662A1 (en) Cell suspension and use thereof
EP2911230A4 (en) CELL
EP2939306A4 (en) DRUMS
EP2831949A4 (en) SODIUM OXYGEN CELLS
HK1252801A1 (zh) 經修飾的紅細胞前體細胞及其用途
IL238880A0 (en) Systems and methods for electrochemical separation
HK1199148A1 (en) Electrochemical cell
HK1210356A1 (en) Cell change in discontinuous mode
EP2899789A4 (en) OXYDOREDUCTION CIRCULATION BATTERY
EP2863459A4 (en) FLAT CELL
EP2864472A4 (en) MATERIALS AND METHODS FOR TREATING CELLULAR POPULATIONS
EP2939294A4 (en) DRUMS
GB201220058D0 (en) Cell differentiation
EP2768048A4 (en) ALKALIC CELL